Since the development of recombinant DNA technology, a new and exciting field of biotechnology has emerged, and the need for specialists in this area has increased nationally. The new biotechnology applies molecular and cell biology to the detection and treatment of human disease and is now a major division of pharmaceutical and research laboratories.
Our goal is to prepare students for employment in research fields available in pharmaceutical companies, universities and hospitals as well as to provide an excellent foundation for students intending to pursue studies in professional health care fields and doctoral programs.
The program provides students with highly specialized lecture and laboratory courses relevant in this rapidly growing field. Quinnipiac’s core curriculum provides comprehensive training in advanced biochemistry, molecular genetics, cell biology and laboratory methods. Electives cover industrial microbiology, virology, immunology, oncology and molecular pathology.
The program supplements Quinnipiac's faculty expertise with scientists from local pharmaceutical, biotechnology and medical school settings. This provides our students with the most efficient and effective educational arena to maximize their success upon completion of their studies.
Students are provided with a choice of thesis options. Each student selecting the thesis option then carries out original laboratory research either in a faculty laboratory or an industrial/hospital research laboratory. Students who choose the nonthesis option must take additional course work and a written comprehensive examination to test their knowledge of core curricula.